
Kyowa Kirin Co. Ltd - Strategy, SWOT and Corporate Finance Report
Description
Kyowa Kirin Co. Ltd - Strategy, SWOT and Corporate Finance Report
Summary
Kyowa Kirin Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Kyowa Kirin Co. Ltd (Kyowa Kirin or 'the company'), a subsidiary of Kirin Holdings Company Limited, is a provider of pharmaceuticals and bio-chemicals. It is primarily involved in the development and distribution of biotechnological products with major focus on oncology, nephrology, and central nervous systems. Its product portfolio includes antihistamine agents, calcium channel blockers, antibodies, glycoprotein, human erythropoietin, oral calcimimetics agents, agent for secondary hyperparathyroidism, and other drugs. The company offers its products under the brands: Leunase, Adriacin, Navelbine, Moventig, Coniel, Gran, Peglasta, Potelifeo, Neulasta, ESPO, Orkedia, Pecfent, Regpara, Romiplate, Sancuso, Allelock and Abstral. These products are used to treat hypertension, allergic reactions, anemia and behavioral disorders and others. The company is headquartered in Tokyo, Japan
Scope
Summary
Kyowa Kirin Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Kyowa Kirin Co. Ltd (Kyowa Kirin or 'the company'), a subsidiary of Kirin Holdings Company Limited, is a provider of pharmaceuticals and bio-chemicals. It is primarily involved in the development and distribution of biotechnological products with major focus on oncology, nephrology, and central nervous systems. Its product portfolio includes antihistamine agents, calcium channel blockers, antibodies, glycoprotein, human erythropoietin, oral calcimimetics agents, agent for secondary hyperparathyroidism, and other drugs. The company offers its products under the brands: Leunase, Adriacin, Navelbine, Moventig, Coniel, Gran, Peglasta, Potelifeo, Neulasta, ESPO, Orkedia, Pecfent, Regpara, Romiplate, Sancuso, Allelock and Abstral. These products are used to treat hypertension, allergic reactions, anemia and behavioral disorders and others. The company is headquartered in Tokyo, Japan
Scope
- Detailed information on Kyowa Kirin Co. Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Kyowa Kirin Co. Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Kyowa Kirin Co. Ltd including a breakdown and examination of key business segments
- Intelligence on Kyowa Kirin Co. Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Kyowa Kirin Co. Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Kyowa Kirin Co. Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Kyowa Kirin Co. Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Kyowa Kirin Co. Ltd's business structure, strategy and prospects.
Table of Contents
60 Pages
- Company Snapshot
- Kyowa Kirin Co. Ltd.: Company Overview
- Kyowa Kirin Co. Ltd.: Overview and Key Facts
- Kyowa Kirin Co. Ltd.: Overview
- Kyowa Kirin Co. Ltd.: Key Facts
- Kyowa Kirin Co. Ltd.: Key Employees
- Kyowa Kirin Co. Ltd.: Key Employee Biographies
- Kyowa Kirin Co. Ltd.: Major Products and Services
- Kyowa Kirin Co. Ltd.: Company History
- Kyowa Kirin Co. Ltd.: Management Statement
- Kyowa Kirin Co. Ltd.: Locations and Subsidiaries
- Kyowa Kirin Co. Ltd.: Key Competitors
- Kyowa Kirin Co. Ltd.: Company Analysis
- Kyowa Kirin Co. Ltd.: Business Description
- Kyowa Kirin Co. Ltd.: SWOT Analysis
- Kyowa Kirin Co. Ltd.: SWOT Overview
- Kyowa Kirin Co. Ltd.: Strengths
- Kyowa Kirin Co. Ltd.: Weaknesses
- Kyowa Kirin Co. Ltd.: Opportunities
- Kyowa Kirin Co. Ltd.: Threats
- Kyowa Kirin Co. Ltd.: Corporate Financial Deals Activity
- Kyowa Kirin Co. Ltd.: Financial Deals Overview
- Kyowa Kirin Co. Ltd.: Targets and Partners
- Kyowa Kirin Co. Ltd.: Top Deals 2018 - 2022YTD*
- Kyowa Kirin Co. Ltd.: Advisors
- Kyowa Kirin Co. Ltd.: Top Legal Advisors
- Kyowa Kirin Co. Ltd.: Top Financial Advisors
- Kyowa Kirin Co. Ltd.: Corporate Venturing
- Kyowa Kirin Co. Ltd.: Partnership
- Kyowa Kirin Co. Ltd.: Divestments
- Kyowa Kirin Co. Ltd.: Recent Developments
- Kyowa Kirin Co. Ltd.: News and Events Summary
- Kyowa Kirin Co. Ltd.: Business Expansion
- Kyowa Kirin Co. Ltd.: Corporate Governance
- Kyowa Kirin Co. Ltd.: Financial Performance
- Kyowa Kirin Co. Ltd.: Regulatory and Legal Events
- Kyowa Kirin Co. Ltd.: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Kyowa Kirin Co. Ltd.: Key Facts
- Table 2: Kyowa Kirin Co. Ltd.: Key Employees
- Table 3: Kyowa Kirin Co. Ltd.: Company History
- Table 4: Kyowa Kirin Co. Ltd.: Locations and Subsidiaries
- Table 5: Kyowa Kirin Co. Ltd.: Key Competitors
- Table 6: Kyowa Kirin Co. Ltd.: Deal Activity by Deal Type - Volume (TTM*)
- Table 7: Kyowa Kirin Co. Ltd.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Table 8: Kyowa Kirin Co. Ltd.: Targets and Partners
- Table 9: Kyowa Kirin Co. Ltd.: Top Deals 2018 - 2022YTD*
- Table 10: Kyowa Kirin Co. Ltd.: Legal Advisor Ranking by Value (US$m)
- Table 11: Kyowa Kirin Co. Ltd.: Financial Advisor Ranking by Value (US$m)
- Table 12: Kyowa Kirin Co. Ltd.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Table 13: Kyowa Kirin Co. Ltd.: Corporate Venturing by Geography (2018 - YTD*2022)
- Table 14: Kyowa Kirin Co. Ltd.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Table 15: Kyowa Kirin Co. Ltd.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Table 16: Kyowa Kirin Co. Ltd.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Table 17: Kyowa Kirin Co. Ltd.: Divestments by Geography (2018 - YTD*2022)
- Table 18: Kyowa Kirin Co. Ltd.: News and Events Summary
- Table 19: Kyowa Kirin Co. Ltd.: Business Expansion
- Table 20: Kyowa Kirin Co. Ltd.: Corporate Governance
- Table 21: Kyowa Kirin Co. Ltd.: Financial Performance
- Table 22: Kyowa Kirin Co. Ltd.: Regulatory and Legal Events
- Table 23: Kyowa Kirin Co. Ltd.: Strategy and Operations
- List of Figures
- Figure 1: Kyowa Kirin Co. Ltd.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Kyowa Kirin Co. Ltd.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
- Figure 3: Kyowa Kirin Co. Ltd.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
- Figure 4: Kyowa Kirin Co. Ltd.: Corporate Venturing by Geography (2018 - YTD*2022)
- Figure 5: Kyowa Kirin Co. Ltd.: Partnership Volume and Value Trend (2018 - YTD*2022)
- Figure 6: Kyowa Kirin Co. Ltd.: Partnership Trend by Deal Type (2018 - YTD*2022)
- Figure 7: Kyowa Kirin Co. Ltd.: Divestments Volume and Value Trend (2018 - YTD*2022)
- Figure 8: Kyowa Kirin Co. Ltd.: Divestments by Geography (2018 - YTD*2022)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.